top
Please input keywords
Order
*Country
United States
China
France
Germany
Netherlands
United Kingdom
Japan
South Korea
Israel
Australia
Hong Kong, China
New Zealand
Russia
Singapore
Taiwan, China
India
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua & Barbuda
Argentina
Armenia
Aruba
Ascension Island
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia & Herzegovina
Botswana
Brazil
British Indian Ocean Territory
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Canary Islands
Cape Verde
Caribbean Netherlands
Cayman Islands
Central African Republic
Ceuta & Melilla
Chad
Chile
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo - Brazzaville
Congo - Kinshasa
Cook Islands
Costa Rica
Côte d’Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czechia
Denmark
Diego Garcia
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
Hungary
Iceland
Indonesia
Iran
Iraq
Ireland
Isle of Man
Italy
Jamaica
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kosovo
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau, China
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar (Burma)
Namibia
Nauru
Nepal
New Caledonia
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territories
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Islands
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Rwanda
Samoa
San Marino
São Tomé & Príncipe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Sint Maarten
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia & South Sandwich Islands
South Sudan
Spain
Sri Lanka
St. Barthélemy
St. Helena
St. Kitts & Nevis
St. Lucia
St. Martin
St. Pierre & Miquelon
St. Vincent & Grenadines
Sudan
Suriname
Svalbard & Jan Mayen
Swaziland
Sweden
Switzerland
Syria
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad & Tobago
Tristan da Cunha
Tunisia
Turkey
Turkmenistan
Turks & Caicos Islands
Tuvalu
U.S. Outlying Islands
U.S. Virgin Islands
Uganda
Ukraine
United Arab Emirates
United Nations
Uruguay
Uzbekistan
Vanuatu
Vatican City
Venezuela
Vietnam
Wallis & Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
*Province
*City
*Name
*Telephone
*Company
*Position
*Email
*Verification code
*Verification Code
B-hC5 MC38
Common name
B-hC5 MC38 Catalog number    311324
Aliases C5Da, C5b, CPAMD4, ECLZB Disease  Colon carcinoma
Organism
Mouse
Strain  C57BL/6
Tissue types Colon Tissue  Colon

Description


The CDS of human C5 was inserted to replace part of murine exon 2 in B-hC5 MC38 cells. Human C5 is highly expressed on the surface of B-hC5 MC38 cells.

Application

B-hC5 MC38 cells have the capability to establish tumors in vivo and can be used for efficacy studies.

Targeting strategy

Gene targeting strategy for B-hC5 MC38 cells. The CDS of human C5 was inserted to replace part of murine exon 2. The insertion disrupts the endogenous murine C5 gene, resulting in a non-functional transcript.

Protein expression analysis 

from clipboard


C5 expression analysis in B-hC5 MC38 cells by ELISA. Supernatant from wild-type MC38 and B-hC5 MC38 cultures were stained with species-specific anti-C5 antibody. Human C5 was detectable in the supernatant of B-hC5 MC38 cells but not in that of wild-type MC38 cells. The 1-G04 clone of B-hC5 MC38 cells was used for in vivo experiments.


Tumor growth curve & Body weight changes


from clipboard

Subcutaneous homograft tumor growth of B-hC5 MC38 cells. B-hC5 MC38 cells (1x106) and wild-type MC38 cells (1x106) were subcutaneously implanted into C57BL/6N mice (female, 7-week-old, n=5). Tumor volume and body weight were measured twice a week. Three mice from each group were sacrificed on day 14 and the other mice were sacrificed at the endpoint. (A) Average tumor volume. (B)  Body weight. Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-hC5 MC38 cells were able to establish tumors in vivo and can be used for efficacy studies. Values are expressed as mean ± SEM.


Protein expression analysis of C5 and C5a in serum and tumor tissues


from clipboard


Strain specific C5 and C5a expression analysis in serum and tumor tissues by ELISA. Wild-type MC38 cells and B-hC5 MC38 cells were subcutaneously inoculated into C57BL/6 mice. Serum and tumors were collected at two time point. One time point is when tumor volume reached 300-500 mm3 (Groups G1-1, G2-1). The other is when part of tumor volume reached 3000 mm3 (Groups G1-2, G2-2). mouse and human C5 and C5a were analyzed by ELISA with species specific anti-C5 antibody and anti-C5a antibody. Mouse C5 and C5a  were detectable in serum and tumor tissues collected from mice inoculated with wild-type MC38 cells and B-hC5 MC38 cells. Human C5 and C5a  were detectable in tumor tissues collected when tumor volume reaced 300-500 mm3 from mice inoculated with B-hC5 MC38 cells. Human C5 and C5a  were not detectable in tumor tissues when tumor volume reached about 3000 mm3.  

Protein expression analysis of C5AR1 in cell line and tumor tissues

from clipboard


Strain specific CD88 (C5AR1) expression analysis in MC38 cell line and tumor by flow cytometry. Wild-type MC38 cells and B-hC5 MC38 cells were subcutaneously inoculated into C57BL/6 mice, and tumors were removed and prepare tumor cells when part of tumor volume reached 3000 mm3. Cultured wild-type MC38 cell line and tumor cells were collected and analyzed by flow cytometry with anti-mCD88 antibody. Mouse CD88 was not detectable on cultured MC38 cell line. But in tumor tissue, mCD88 was expressed in most of the CD45+ cells and it was expressed in a small number of CD45− cells.